CN101112537A - Chinese traditional medicine preparations for treating hyperosteogeny disease - Google Patents

Chinese traditional medicine preparations for treating hyperosteogeny disease Download PDF

Info

Publication number
CN101112537A
CN101112537A CNA2007100559627A CN200710055962A CN101112537A CN 101112537 A CN101112537 A CN 101112537A CN A2007100559627 A CNA2007100559627 A CN A2007100559627A CN 200710055962 A CN200710055962 A CN 200710055962A CN 101112537 A CN101112537 A CN 101112537A
Authority
CN
China
Prior art keywords
radix
rhizoma
root
chinese medicine
rehmanniae preparata
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CNA2007100559627A
Other languages
Chinese (zh)
Other versions
CN100566742C (en
Inventor
陈玉龙
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB2007100559627A priority Critical patent/CN100566742C/en
Publication of CN101112537A publication Critical patent/CN101112537A/en
Application granted granted Critical
Publication of CN100566742C publication Critical patent/CN100566742C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The present invention discloses a traditional Chinese medicine preparation for treating hyperosteogeny disease, which is composed of tall gastrodia tuber, garden balsam stem, safflower, sanchi, Szechuan lovage rhizome, danshen root, ground beetle, yanhusuo, largeleaf gentian root, incised notopterygium rhizome, doubleteeth pubescent angilica root, little multibanded krait, cassia twig, eucommia bark, medicinal cyathula root, rhizome, radix rehmanniae preparata, east Asian tree fern rhizome, himalayan teasel root, tuber fleeceflower root (roasted), Chinese magnoliavine fruit, ginseng, nutgrass galingale rhizome, cassia bark and common clubmoss herb; except the radix rehmanniae preparata and the eucommia bark which have the greater viscosity, other 23 traditional Chinese medicines of the above medicines are weighed in proportion, the fine powder is obtained by passing through the 100 to 200 mesh screen, then the radix rehmanniae preparata and the eucommia bark are weighed in proportion and mixed evenly, then the fine powder is obtained by passing through the 100 to 200 mesh screen, so as to get the traditional Chinese medicine powder of the present invention. The present invention is the pure traditional Chinese medicine preparation and is characterized by treating both manifestation and root cause of disease, synchronous treatment and nourishing, no gastrointestinal adverse reactions, short treatment course, fast efficacy, high one-time cure rate, less toxicity and side effects, less rebound phenomenon after the cure, low cost and so on.

Description

The Chinese medicine preparation of treatment hyperosteogeny disease
Technical field
The present invention discloses a kind of Chinese medicine preparation for the treatment of hyperosteogeny disease, belongs to the Chinese medicine technical field.
Technical background
At present, the oral preparation of Chinese traditional medicinal of treatment hyperosteogeny is a lot of on the medical market, and therapeutic effect varies, and most of Chinese medicine preparation all have the different gastrointestinal side effect of degree, and therapeutic effect is also unsatisfactory, cures the symptoms, not the disease, and side effect is many, and is of common occurrence.
Summary of the invention
The present invention discloses a kind of Chinese medicine preparation for the treatment of hyperosteogeny disease, is pure Chinese medicinal preparation, and is evident in efficacy, shortens treatment cycle, reduces medical expense, improves therapeutic effect, simplifies Therapeutic Method.
The present invention is according to motherland's theory of Chinese medical science, pathogenesis and Therapeutic Principle in conjunction with hyperosteogeny disease, selected pure Chinese herbal medicine with expelling wind and removing dampness, dispelling cold by warming the meridian, supporing yang activating QI, blood circulation promoting and blood stasis dispelling, suppressing the hyperactive liver the kidney invigorating, bone and muscle strengthening, benefiting QI and nourishing blood, removing obstruction in the collateral to relieve pain is made pharmaceutical preparation by traditional Chinese medicine processing technology.
Concrete medicine is formed the column weight amount umber ratio of pressing:
Rhizoma Gastrodiae 38~50, Herba speranskiae tuberculatae 30~45, Radix Notoginseng 30~45, Flos Carthami 20~35,
Rhizoma Chuanxiong 35~45, Radix Salviae Miltiorrhizae 35~45, eupolyphage sece steleophaga 15~25, Rhizoma Corydalis 20~30,
Radix Gentianae Macrophyllae 20~30, Rhizoma Et Radix Notopterygii 20~35, Radix Angelicae Pubescentis 20~35, Agkistrodon 2~3,
Ramulus Cinnamomi 18~30, the Cortex Eucommiae 25~30, Radix Achyranthis Bidentatae 18~30, Rhizoma Polygonati 20~28,
Radix Rehmanniae Preparata 20~28, Rhizoma Cibotii 18~28, Radix Dipsaci 18~28, Radix Polygoni Multiflori (processing) 20~30,
Fructus Schisandrae Chinensis 18~28, Radix Ginseng 16~24, Rhizoma Cyperi 15~25, Cortex Cinnamomi 8~15,
Herba Lycopodii 30~45.
Preferred prescription is as follows:
Rhizoma Gastrodiae 45, Herba speranskiae tuberculatae 40, Flos Carthami 30, Radix Notoginseng 35, Rhizoma Chuanxiong 40, Radix Salviae Miltiorrhizae 40,
Eupolyphage sece steleophaga 20, Rhizoma Corydalis 25, Radix Gentianae Macrophyllae 25, Rhizoma Et Radix Notopterygii 25, Radix Angelicae Pubescentis 32, Agkistrodon 3,
Ramulus Cinnamomi 20, the Cortex Eucommiae 25, Radix Achyranthis Bidentatae 20, Rhizoma Polygonati 23, Radix Rehmanniae Preparata 25, Rhizoma Cibotii 20,
Radix Dipsaci 23, Radix Polygoni Multiflori (processing) 25, Fructus Schisandrae Chinensis 20, Radix Ginseng 18, Rhizoma Cyperi 15,
Cortex Cinnamomi 12, Herba Lycopodii 33.
Concrete processing procedure: except that Radix Rehmanniae Preparata, Cortex Eucommiae viscosity were big, all the other 23 flavor Chinese medicines took by weighing in proportion with said medicine, through 100~200 order fine powders, again the Radix Rehmanniae Preparata and the Cortex Eucommiae are taken by weighing in proportion uniform mixing, through 100~200 order fine powders, promptly obtain Chinese medicine powder of the present invention.
Take by weighing by per 5~10 gram portions, once a, a twice-daily, eliminating cold for resuscitation mouth of a river clothes in the meal, 30 days is a course of treatment.
This medicated powder can also be made tablet, capsule, the watered pill, honeyed pill and granule.
Side of the present invention separates with pharmacology analysis as follows:
Medicine of the present invention mostly is the medicine of blood circulation promoting and blood stasis dispelling, expelling wind and removing dampness, suppressing the hyperactive liver and subsiding YANG, bone and muscle strengthening, wherein: Rhizoma Gastrodiae: sweet, flat, the suppressing the hyperactive liver to relieve the wind syndrome relieving convulsion; Herba speranskiae tuberculatae: hot, warm, expelling wind and removing dampness, relaxing muscles and tendons to promote blood circulation.Pain relieving, two medicines 5 are played mutually altogether: the effect of expelling wind and removing dampness, relaxing muscles and tendons and activating QI and blood in the collateral, promoting blood circulation and stopping pain, suppressing the hyperactive liver the kidney invigorating is monarch drug altogether.The shared effect that can strengthen blood circulation promoting and blood stasis dispelling, expelling wind and removing dampness, dispelling cold by warming the meridian, supporing yang activating QI, benefiting QI and nourishing blood, suppressing the hyperactive liver the kidney invigorating, bone and muscle strengthening, removing obstruction in the collateral to relieve pain of 17 flavor Chinese medicines such as Flos Carthami, Radix Notoginseng, Rhizoma Chuanxiong, Rhizoma Corydalis, Rhizoma Et Radix Notopterygii, Radix Angelicae Pubescentis, Radix Ginseng, Rhizoma Cyperi, Cortex Cinnamomi, Radix Dipsaci, Radix Polygoni Multiflori, Herba Lycopodii, Fructus Schisandrae Chinensis, Rhizoma Cibotii, the Cortex Eucommiae, Radix Rehmanniae Preparata, Agkistrodon is ministerial drug altogether.4 flavor Chinese medicines such as Radix Salviae Miltiorrhizae, eupolyphage sece steleophaga, Rhizoma Polygonati, Radix Gentianae Macrophyllae are adjuvant drug, the shared effect that can strengthen blood circulation promoting and blood stasis dispelling, removing obstruction in the collateral to relieve pain, clearing away heat-damp and promoting diuresis, life essence-filling, marrow-benefitting, benefiting QI and nourishing blood, suppressing the hyperactive liver the kidney invigorating.Radix Achyranthis Bidentatae: bitter, acid, flat, invigorating the liver and kidney, bone and muscle strengthening, eliminating blood stasis and inducing menstruation, conducting blood to flow downwards: Ramulus Cinnamomi: hot, warm, relieving the exterior syndrome by diaphoresis, warming the meridian and promoting blood circulation, supporing yang activating QI, two medicines mutually 5 increase promoting the flow of QI in the collateral by warming the meridian, blood circulation promoting and blood stasis dispelling jointly, dispel the wind and carry the effect of few, suppressing the hyperactive liver the kidney invigorating, bone and muscle strengthening, relaxing muscles and tendons and activating QI and blood in the collateral, be messenger drug altogether, play all medicine effects of guiding.
More than 25 flavor Chinese medicines shared, can reach the effect of expelling wind and removing dampness, dispelling cold by warming the meridian, supporing yang activating QI, blood circulation promoting and blood stasis dispelling, suppressing the hyperactive liver the kidney invigorating, bone and muscle strengthening, benefiting QI and nourishing blood, removing obstruction in the collateral to relieve pain.
Differential diagnosis in tcm: wind chill blockage, cold-damp resistance network, phlegm-damp intrinsic heat, qi depression to blood stasis, muscle lose and moisten foster, deficiency of qi and blood, caused by liver and kidney deficiency, kidney yang deficiency.
Indication: expelling wind and removing dampness, dispelling cold by warming the meridian, activating blood circulation and supplementing qi, removing obstruction in the collateral to relieve pain, suppressing the hyperactive liver the kidney invigorating, bone and muscle strengthening.
Be mainly used in: various hyperosteogenys, ligament calcification and rheumatism.Comprise vertebrae hyperosteogeny, intervertebral disk hernia, spinal canal stenosis, ankylosing spondylitis, gouty arthritis, ligamenta intervertebralia calcification, intervertebral foramina stenosis, mismatch of thoracis vertbra small joint, lumbar spondylolisthesis etc.Can also be used for each arthralgia that rheumatism and rheumatism cause, hyperosteogeny etc.
Good effect of the present invention is: has treating both the principal and secondary aspects of a disease, controls and mend synchronous, no gastrointestinal side effect, and short treating period, rapid-action, the one-time cure rate height, toxic and side effects is little, controls characteristics such as afterwards rebound phenomena is few, and expense is low.
For showing the therapeutic effect of medicine of the present invention, selected 104 routine patients treat with medicine of the present invention, carry out statistical analysis through system's clinical observation and are summarized as follows:
Diagnosis basis:
(1) x line, cR sheet, cT sheet, the diagnosis of MRI sheet;
(2) the various clinical symptoms of doctor trained in Western medicine case regulation.
Diagnostic criteria:
Cure: various clinical symptom disappearance.
Effectively: various clinical symptoms are obviously improved.
Invalid: various clinical symptoms do not have improvement.
The 104 routine hyperosteogeny patients that use Drug therapy of the present invention are carried out statistical analysis, cure 83 examples, cure rate is 79.9%; Produce effects 12 examples; Effective 7 examples (2 example allergy are wherein arranged); Total effective rate is 98.1%.Invalid 2 examples, inefficiency are 1.9%.
Case 1: Pan xx, man, 64 years old, cervical vertebra 3~7 joint hyperosteogenys, the ligament calcification is before the treatment: dizziness, cardiopalmus, unstable blood pressure (+), restriction of neck motion, snap (+), go up angle tenderness, radiating pain (+) in right hand numbness, the right omoplate, brachial plexus distraction test (+), pressure head test (+).Treatment back: dizziness, cardiopalmus, unstable blood pressure
(-), restriction of neck motion, snap (-) are gone up angle tenderness, radiating pain (-) in right hand numbness, the right omoplate, brachial plexus distraction test (-), pressure head test (-).
Case 2: certain man, 62 years old, cervical vertebra 3~4 joint hyperosteogenys, companion's spinal canal stenosis, before the treatment: dizzy, headache (+), cardiopalmus, breathe hard (+), unstable blood pressure (+), the cervical region activity is seriously limited, snap (+), the following sensory disturbance of cervical vertebra 3~4 pitch planes, movement disorder (+), pressure head test (+), brachial plexus distraction test (+).
The treatment back: dizzy, headache (-), cardiopalmus, breathe hard (-), unstable blood pressure (-), the cervical region activity is seriously limited, snap (-), the following sensory disturbance of cervical vertebra 3~4 pitch planes, movement disorder (-), pressure head test (-), brachial plexus distraction test (-).
Case 3: certain man, 60 years old, lumbar vertebra 3~4 internode dish bulgings, companion's lumbar vertebra 3~caudal vertebra 1 hyperosteogeny, lumbar vertebra 5~caudal vertebra 1 spinal canal stenosis.Before the treatment: deadlock in morning (+), alternately walk lamely (+), body deflection (+), the other tenderness of vertebra, radiating pain (+), waist hyperextension test (+), straight lower limb is raised and applied voltage test (+) pick-up test (+) of bending over.The treatment back: deadlock in morning (-), alternately walk lamely (-), body deflection (-), the other tenderness of vertebra, radiating pain (-), waist hyperextension test (-), straight lower limb is raised and applied voltage test (-) pick-up test (-) of bending over.
Above case was followed up a case by regular visits to after 1 year, all not recurrence.
The specific embodiment
For the ease of understanding the present invention, especially exemplified by following examples.Its effect is understood that it is to explaination of the present invention but not to any type of restriction of the present invention.
Embodiment 1
Take by weighing following medicine (unit: kilogram): Rhizoma Gastrodiae 45, Herba speranskiae tuberculatae 40, Flos Carthami 30, Radix Notoginseng 35, Rhizoma Chuanxiong 40, Radix Salviae Miltiorrhizae 40, eupolyphage sece steleophaga 20, Rhizoma Corydalis 25, Radix Gentianae Macrophyllae 25, Rhizoma Et Radix Notopterygii 25, Radix Angelicae Pubescentis 32, Agkistrodon 3, Ramulus Cinnamomi 20, the Cortex Eucommiae 25, Radix Achyranthis Bidentatae 20, Rhizoma Polygonati 23, Radix Rehmanniae Preparata 25, Rhizoma Cibotii 20, Radix Dipsaci 23, Radix Polygoni Multiflori (system) 25, Fructus Schisandrae Chinensis 20, Radix Ginseng 18, Rhizoma Cyperi 15, Cortex Cinnamomi 12, Herba Lycopodii 33.
Concrete processing procedure: except that Radix Rehmanniae Preparata, Cortex Eucommiae viscosity were big, all the other 23 flavor Chinese medicines took by weighing in proportion, through 100~200 order fine powders, the Radix Rehmanniae Preparata and the Cortex Eucommiae are taken by weighing in proportion again, and uniform mixing through 100~200 order fine powders, promptly obtains Chinese medicine powder of the present invention.
Embodiment 2
(unit: kilogram): Rhizoma Gastrodiae 38, Herba speranskiae tuberculatae 30, Flos Carthami 25, Radix Notoginseng 35, Rhizoma Chuanxiong 35, Radix Salviae Miltiorrhizae 45, eupolyphage sece steleophaga 15, Rhizoma Corydalis 20, Radix Gentianae Macrophyllae 20, Rhizoma Et Radix Notopterygii 35, Radix Angelicae Pubescentis 20, Agkistrodon 2, Ramulus Cinnamomi 30, Radix Achyranthis Bidentatae 18, Rhizoma Polygonati 20, Rhizoma Cibotii 25, Radix Dipsaci 25, Radix Polygoni Multiflori (system) 20, Fructus Schisandrae Chinensis 18, Radix Ginseng 24, Rhizoma Cyperi 25, Cortex Cinnamomi 8, Herba Lycopodii 45 are ground into 100~200 order fine powders with following medicine, with Radix Rehmanniae Preparata 20, the Cortex Eucommiae 30 uniform mixing, through 100~200 order fine powders, promptly obtain Chinese medicine powder of the present invention.
Embodiment 3
Take by weighing following medicine (unit: kilogram): Rhizoma Gastrodiae 50, Herba speranskiae tuberculatae 45, Flos Carthami 35, Radix Notoginseng 45, Rhizoma Chuanxiong 45, Radix Salviae Miltiorrhizae 35, eupolyphage sece steleophaga 25, Rhizoma Corydalis 30, Radix Gentianae Macrophyllae 30, Rhizoma Et Radix Notopterygii 20, Radix Angelicae Pubescentis 30, Agkistrodon 3, Ramulus Cinnamomi 20, the Cortex Eucommiae 28, Radix Achyranthis Bidentatae 30, Rhizoma Polygonati 28, Radix Rehmanniae Preparata 28, Rhizoma Cibotii 28, Radix Dipsaci 18, Radix Polygoni Multiflori (system) 30, Fructus Schisandrae Chinensis 28, Radix Ginseng 16, Rhizoma Cyperi 20, Cortex Cinnamomi 8, Herba Lycopodii 45.
Concrete processing procedure: except that Radix Rehmanniae Preparata, Cortex Eucommiae viscosity were big, all the other 23 flavor Chinese medicines took by weighing in proportion, through 100~200 order fine powders, the Radix Rehmanniae Preparata and the Cortex Eucommiae are taken by weighing in proportion again, and uniform mixing through 100~200 order fine powders, promptly obtains Chinese medicine powder of the present invention.

Claims (3)

1. Chinese medicine preparation for the treatment of hyperosteogeny disease is characterized in that it being to be made by following materials of weight proportions medicine:
Rhizoma Gastrodiae 38~50, Herba speranskiae tuberculatae 30~45, Radix Notoginseng 30~45, Flos Carthami 20~35,
Rhizoma Chuanxiong 35~45, Radix Salviae Miltiorrhizae 35~45, eupolyphage sece steleophaga 15~25, Rhizoma Corydalis 20~30,
Radix Gentianae Macrophyllae 20~30, Rhizoma Et Radix Notopterygii 20~35, Radix Angelicae Pubescentis 20~35, Agkistrodon 2~3,
Ramulus Cinnamomi 18~30, the Cortex Eucommiae 25~30, Radix Achyranthis Bidentatae 18~30, Rhizoma Polygonati 20~28,
Radix Rehmanniae Preparata 20~28, Rhizoma Cibotii 18~28, Radix Dipsaci 18~28, Radix Polygoni Multiflori (processing) 20~30,
Fructus Schisandrae Chinensis 18~28, Radix Ginseng 16~24, Rhizoma Cyperi 15~25, Cortex Cinnamomi 8~15,
Herba Lycopodii 30~45.
2. Chinese medicine preparation according to claim 1 is characterized in that it being to be made by following materials of weight proportions medicine:
Rhizoma Gastrodiae 45, Herba speranskiae tuberculatae 40, Flos Carthami 30, Radix Notoginseng 35, Rhizoma Chuanxiong 40, Radix Salviae Miltiorrhizae 40,
Eupolyphage sece steleophaga 20, Rhizoma Corydalis 25, Radix Gentianae Macrophyllae 25, Rhizoma Et Radix Notopterygii 25, Radix Angelicae Pubescentis 32, Agkistrodon 3,
Ramulus Cinnamomi 20, the Cortex Eucommiae 25, Radix Achyranthis Bidentatae 20, Rhizoma Polygonati 23, Radix Rehmanniae Preparata 25, Rhizoma Cibotii 20,
Radix Dipsaci 23, Radix Polygoni Multiflori (processing) 25, Fructus Schisandrae Chinensis 20, Radix Ginseng 18, Rhizoma Cyperi 15,
Cortex Cinnamomi 12, Herba Lycopodii 33.
3. Chinese medicine preparation according to claim 1 and 2 is a said dosage form on any pharmaceutics.
CNB2007100559627A 2007-08-15 2007-08-15 The Chinese medicine preparation of treatment hyperosteogeny disease Expired - Fee Related CN100566742C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2007100559627A CN100566742C (en) 2007-08-15 2007-08-15 The Chinese medicine preparation of treatment hyperosteogeny disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2007100559627A CN100566742C (en) 2007-08-15 2007-08-15 The Chinese medicine preparation of treatment hyperosteogeny disease

Publications (2)

Publication Number Publication Date
CN101112537A true CN101112537A (en) 2008-01-30
CN100566742C CN100566742C (en) 2009-12-09

Family

ID=39021167

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2007100559627A Expired - Fee Related CN100566742C (en) 2007-08-15 2007-08-15 The Chinese medicine preparation of treatment hyperosteogeny disease

Country Status (1)

Country Link
CN (1) CN100566742C (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102526540A (en) * 2012-03-21 2012-07-04 刘金鑫 Medicinal composition with effect of relieving pain of main and collateral channels
CN102772617A (en) * 2012-02-16 2012-11-14 王建国 Medicine for treating disease of hyperosteogeny
CN103479837A (en) * 2013-09-02 2014-01-01 张金学 External medicine for curing hyperosteogeny and preparation method thereof
CN104324340A (en) * 2014-12-03 2015-02-04 汤玮 Traditional Chinese medicine preparation for treating calcaneal bone hyperplasia and preparation method of traditional Chinese medicine preparation
CN105797110A (en) * 2016-04-21 2016-07-27 广西嘉进药业股份有限公司 Traditional Chinese medicine composition for treating osteoarticular diseases and preparation method thereof
CN109106918A (en) * 2018-11-08 2019-01-01 邹正年 A kind of Chinese medicine and preparation method thereof for treating rheumatism bone disease

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102772617A (en) * 2012-02-16 2012-11-14 王建国 Medicine for treating disease of hyperosteogeny
CN102772617B (en) * 2012-02-16 2014-05-14 王建国 Medicine for treating disease of hyperosteogeny
CN102526540A (en) * 2012-03-21 2012-07-04 刘金鑫 Medicinal composition with effect of relieving pain of main and collateral channels
CN103479837A (en) * 2013-09-02 2014-01-01 张金学 External medicine for curing hyperosteogeny and preparation method thereof
CN103479837B (en) * 2013-09-02 2015-07-22 张金学 External medicine for curing hyperosteogeny and preparation method thereof
CN104324340A (en) * 2014-12-03 2015-02-04 汤玮 Traditional Chinese medicine preparation for treating calcaneal bone hyperplasia and preparation method of traditional Chinese medicine preparation
CN104324340B (en) * 2014-12-03 2017-07-14 汤玮 It is a kind of to treat Chinese medicine preparation of heel bone hyperosteogeny and preparation method thereof
CN105797110A (en) * 2016-04-21 2016-07-27 广西嘉进药业股份有限公司 Traditional Chinese medicine composition for treating osteoarticular diseases and preparation method thereof
CN109106918A (en) * 2018-11-08 2019-01-01 邹正年 A kind of Chinese medicine and preparation method thereof for treating rheumatism bone disease

Also Published As

Publication number Publication date
CN100566742C (en) 2009-12-09

Similar Documents

Publication Publication Date Title
CN100423761C (en) Chinese medicinal preparation for treating fracture, traumatic injury
CN103735641B (en) Medicine for the treatment of fracture and preparation method thereof
CN100566742C (en) The Chinese medicine preparation of treatment hyperosteogeny disease
CN104873631A (en) Traditional Chinese medicinal composition for treating bone diseases, preparation method of traditional Chinese medicinal composition and bone disease therapeutic apparatus
CN1539479A (en) Drug for curing disease of proplapse of lumbar intervertebral disc
CN104225508A (en) Traditional Chinese medicine composition for cervical spondylosis treatment and preparation method thereof
CN103550380B (en) Traditional Chinese medicine composition for treating hyperostosis
CN101897879A (en) Traditional Chinese medicine for treating rheumatic arthritis
CN103446360B (en) Traditional Chinese medicine capsule preparation for treating lumbar disc herniation and preparation method of traditional Chinese medicine capsule preparation
CN104922363A (en) Traditional Chinese medicine composite for treating osteoproliferation
CN103800840A (en) Oral traditional Chinese medicine solution for treating cervical spondylosis
CN101897928B (en) Medicinal composition for treating ankylosing spondylitis and preparation method
CN105213766B (en) A kind of dredging collateral supports knee soup and preparation method thereof
CN102579672A (en) Medicament for treating bone hyperplasia and lumbar disc herniation
CN106511905A (en) Traditional Chinese medicine preparation used for curing cervical spondylosis and preparation method thereof
CN102370688A (en) Compound Chinese medicinal preparation for treating hyperosteogeny and preparation method thereof
CN103212044B (en) Traditional Chinese medicine composition for treating cardiovascular diseases
CN101284087B (en) Medicinal composition for curing lumbar disease
CN102018815A (en) Chinese medicine preparation for treating tuberculosis of lumbar spine
CN1970067B (en) Chinese medicinal formulation for treating vertebrae hyperosteogeny, protrusion of intervertebral disc and spinal stenosis
CN105169279A (en) Traditional Chinese medicine composition for treating knee joint bone hyperplasia
CN102872287A (en) Traditional Chinese medicine composition for treating femoral head necrosis and preparation method thereof
CN102028810B (en) Traditional Chinese medicine for treating lumbar intervertebral disc protrusion
CN102058681A (en) Traditional Chinese medicine for treating protrusion of lumbar vertebral disc and waist and leg pain and preparation method thereof
CN106166275A (en) A kind of decoction medicine treating chronic cervical syndrome and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20091209

Termination date: 20120815